Oxford Biomedica says Phase III QUASAR trial for Trovax to progress : Oxford BioMedica Plc. said the Independent Oncology Clinical Trials Office (OCTO) remains committed to the QUASAR V Phase III trial for TroVax in colorectal cancer although the trial, along with the rest of the Trovax...
Register for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Coppock Curve and ZigZag.
Get the Latest Oxford Biomedica Share Price, quotes, trades and FREE real-time Oxford Biomedica stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical Share prices for Oxford Biomedica (OXB) and other London Stock Exchange listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.
Receive the lastest Oxford Biomedica share price by texting afn q OXB to 60030 and receive the current Oxford Biomedica share price, the bid and offer price as well as the day's high, low and opening prices.
The service provides quotes for London Stock Exchange listed stocks and covered warrants, PLUS and FOREX (Foreign Exchange). Each message costs 25p. Not available to Virgin mobile users.